Gene: TREM2
Official Full Name: triggering receptor expressed on myeloid cells 2provided by HGNC
Gene Summary: This gene encodes a membrane protein that forms a receptor signaling complex with the TYRO protein tyrosine kinase binding protein. The encoded protein functions in immune response and may be involved in chronic inflammation by triggering the production of constitutive inflammatory cytokines. Defects in this gene are a cause of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Nov 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00593 | TREM2 gRNA3-gRNA4 KO plasmid | TREM2 | $850 | |||
KO00799 | TREM2 Knockout cell line(THP-1) | Human | TREM2 | 1:2-1:4 | Negative | Online Inquiry |
TREM2 Gene Knockout Cell Lines are genetically engineered cell lines that have been specifically designed to lack the TREM2 (Triggering Receptor Expressed on Myeloid Cells 2) gene. This product serves as a crucial tool in the study of neuroinflammation and neurodegenerative diseases such as Alzheimer's disease. By removing TREM2, which plays a vital role in microglial function and immune response in the central nervous system, researchers can investigate the mechanisms underlying various pathological conditions associated with neuroinflammation.
The primary mechanism through which TREM2 operates involves the modulation of inflammatory responses and phagocytosis in immune cells. The absence of this gene in these knockout cell lines allows scientists to explore changes in signaling pathways and cellular activities, particularly those related to microglial activation and the clearance of amyloid plaque aggregates. This can deepen our understanding of TREM2's involvement in neurodegeneration, offering insights into potential therapeutic targets for treatment.
From a scientific standpoint, the TREM2 Gene Knockout Cell Lines are invaluable in both research and clinical settings. They provide an effective model for studying molecular interactions and pathways in neuroinflammatory conditions, giving researchers the ability to validate hypotheses regarding the role of TREM2 in health and disease. Furthermore, these cell lines facilitate the evaluation of drug candidates targeting related pathways, making them an essential resource in the field of neurobiology.
Compared to alternative cell models, such as wild-type cell lines, TREM2 Gene Knockout Cell Lines present unique advantages by allowing for precise insights into the specific impact of the TREM2 deficiency. As a result, they lead to more targeted and meaningful experimental outcomes.
The value of TREM2 Gene Knockout Cell Lines to researchers and clinicians lies in their ability to streamline the investigation of neurodegenerative processes, ultimately fostering advancements in therapeutic strategies. Our company, with a strong commitment to supporting scientific innovation, specializes in providing high-quality biological products that meet the diverse needs of the research community, ensuring that you have the tools necessary to push the boundaries of discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.